S.M.A. van der Pol

20012024

Research activity per year

Network

Anke Vennegoor

Person: Academic

Laura Peferoen

Person: Academic

Kevin Mol

Person: Academic

Chris Polman

Person: Academic

Riekeld Scheper

Person: Academic

Evert-Jan Kooi

Person: Academic

Bert Van het Hof

  • VU University Medical Center
  • Vrije Universiteit Amsterdam

External person

Ernesto Rodríguez

  • Vrije Universiteit Amsterdam

External person

Jack Van Horssen

  • Vrije Universiteit Amsterdam

External person

Britta Engelhardt

  • University of Bern

External person

Ernesto Rodriguez

  • Vrije Universiteit Amsterdam

External person

Erwin L A Blezer

  • Utrecht University

External person

David Maussang

  • VU University Medical Hospital
  • Vrije Universiteit Amsterdam
  • to-BBB technologies BV (now 2-BBB Medicines BV)

External person

Jon D Laman

  • University Medical Center Groningen
  • MS Center Noord-Nederland
  • University of Groningen
  • Erasmus Universiteit Rotterdam
  • Netherlands Organisation for Applied Scientific Research
  • Dartmouth School

External person

D. Baker

  • Queen Mary University of London

External person

Nikki van Driel

  • Biomedical Primate Research Center

External person

Serena Ruggieri

  • San Camillo Hospital
  • University of Rome La Sapienza

External person

Diego Centonze

  • IRCCS Istituto Neurologico Mediterraneo Neuromed - Pozzilli (IS)

External person

Tomás Sobrino

  • Clinical University Hospital
  • Health Research Institute of Santiago de Compostela (IDIS)

External person

Melanie Loix

  • School of Life Sciences, Diepenbeek, Belgium

External person

Iliana Michailidou

  • Academic Medical Centre Amsterdam
  • Leiden University

External person

Evelien Drost

  • Vrije Universiteit Amsterdam

External person

Hans Lassmann

  • Medical University of Vienna

External person

Jan Ake Gustafsson

  • Center for Nuclear Receptors and Cell Signaling, Houston, United States
  • Division of Clinical Chemistry, Stockholm, Sweden

External person

I. L. Schadee-Eestermans

  • VU Medisch Centrum

External person

Jordon Dunham

  • Biomedical Primate Research Center
  • University Medical Center Groningen

External person

Marco de Boer

  • to-BBB technologies BV (now 2-BBB Medicines BV)

External person

Don J. Mahad

  • University of Edinburgh

External person

Dorine Wouters

  • Amsterdam University Medical Centers

External person

Tim Vanmierlo

  • Hasselt University
  • School of Life Sciences
  • Maastricht University
  • Hasselt University/Transnational University Limburg

External person

Gerty Schreibelt

  • Radboud University Medical Center

External person

Yolanda S Kap

  • Biomedical Primate Research Center
  • Erasmus Universiteit Rotterdam

External person

Wolfgang Liedtke

  • Duke University

External person

Louis Boon

  • Macrozyme BV
  • Bioceros

External person

Nicholas D. Mazarakis

  • Imperial College London

External person

Graham R. Campbell

  • University of Edinburgh

External person

Claudio Gasperini

  • San Camillo Hospital

External person

Jaap Rip

  • University of Amsterdam
  • to-BBB technologies BV (now 2-BBB Medicines BV)

External person

Richard Reynolds

  • Imperial College London
  • Nanyang Technological University

External person

Daniela Sommer

  • School of Life Sciences, Diepenbeek, Belgium
  • Amsterdam University Medical Centers

External person

Neda Haghayegh Jahromi

  • University of Bern

External person

Roosmarijn E. Vandenbroucke

  • Flanders Institute for Biotechnology
  • Ghent University

External person

G. Pryce

  • Queen Mary University of London

External person

J. Bauer

  • Vrije Universiteit Amsterdam

External person

Jasmine Vanmol

  • Hasselt University
  • School of Life Sciences

External person

Esther M.L. Hendrikx

  • VU University Medical Center

External person

Christian Weber

  • RWTH Aachen University
  • Ludwig Maximilian University of Munich
  • German Centre for Cardiovascular Research
  • Maastricht University
  • Munich Cluster for Systems Neurology (SyNergy)

External person

Rachel James

  • Imperial College London

External person

John G Collard

  • Netherlands Cancer Institute
  • Amsterdam University Medical Centers

External person

Silvia Martina Tietz

  • University of Bern

External person

Jan Bauer

  • Medical University of Vienna
  • Medical Faculty

External person

Elien Wouters

  • School of Life Sciences

External person

Jacob van den Born

  • Radboud University Nijmegen

External person

Pieter J Gaillard

  • to-BBB technologies BV (now 2-BBB Medicines BV)

External person

Boyd Kenkhuis

  • Leiden University

External person

Lydian Knoop

  • Vrije Universiteit Amsterdam

External person

Carmen Picon

  • Imperial College London

External person

Dennis Wever

  • Amsterdam UMC

External person

G. Storm

  • Utrecht University
  • University of Twente
  • National University of Singapore

External person

Bert Adriaan 't Hart

  • Biomedical Primate Research Center
  • University Medical Center Groningen

External person

Linda Chen

  • to-BBB technologies BV (now 2-BBB Medicines BV)

External person

Burt van der Boom

  • to-BBB technologies BV (now 2-BBB Medicines BV)

External person

Danielle W R Wessels

  • Department of Molecular Cell Biology and Immunology

External person

Daan Verhaege

  • Amsterdam UMC
  • Flanders Institute for Biotechnology
  • Ghent University

External person

Wolfgang M. Kuebler

  • Charité – Universitätsmedizin Berlin
  • University of Toronto
  • German Centre for Cardiovascular Research
  • Keenan Research Centre for Biomedical Science

External person

Knut R. Steffensen

  • Division of Clinical Chemistry, Stockholm, Sweden

External person

Wia Baron

  • University Medical Center Groningen
  • University of Groningen

External person

Joan van Kregten

  • to-BBB technologies BV (now 2-BBB Medicines BV)

External person

Willeke M.C. Van Roon-Mom

  • Leiden University Medical Centre

External person

K Nicolay

  • Utrecht University

External person

Angelique van den Heuvel

  • to-BBB technologies BV (now 2-BBB Medicines BV)

External person

Laura Michalick

  • Charité – Universitätsmedizin Berlin
  • German Centre for Cardiovascular Research

External person

Rob A van der Kammen

  • Netherlands Cancer Institute

External person

Marko A. Popovic

  • Netherlands Institute for Neuroscience
  • Amsterdam UMC

External person